Back to contract actions
Awarding Agency
Sub-Agency
National Institutes of Health
Start Date
July 1, 2020
End Date
January 18, 2027
NAICS
PSC
AN12
Description
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Transactions (16)
| Date | Mod # | Obligation |
|---|---|---|
| Jun 29, 2020 | 0 | +$3,229,128 |
| Sep 11, 2020 | P00001 | +$0 |
| Dec 21, 2021 | P00002 | +$0 |
| May 26, 2022 | P00003 | +$2,954,004 |
| Sep 16, 2022 | P00004 | +$4,486,144 |
| Jan 9, 2023 | P00005 | +$0 |
| May 16, 2023 | P00006 | +$4,711,879 |
| Aug 29, 2023 | P00007 | +$0 |
| Jul 1, 2024 | P00008 | +$9,407,873 |
| Aug 1, 2024 | P00009 | +$0 |
| Sep 10, 2024 | P00010 | +$0 |
| Nov 22, 2024 | P00011 | +$0 |
| Jul 31, 2025 | P00012 | +$255,865 |
| Jan 16, 2026 | P00013 | +$0 |
| Jul 23, 2026 | P00014 | +$0 |
| Sep 14, 2026 | P00015 | +$0 |